ARUP Laboratories-医療機器分野:企業M&A・提携分析

◆英語タイトル:ARUP Laboratories - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011258
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ARUP Laboratories (ARUP) is a clinical and anatomical pathology reference laboratory. It is a nonprofit enterprise of the University of Utah and its Department of Pathology. The company provides several tests and test combinations in the fields of anatomic pathology, genetics, pain management, general oncology, hematologic oncology, hemostasis/thrombosis, immuno-hematology, molecular infectious disease, pediatric conditions, transplantation, and veterinary pathology. The company performs 99% of tests on site. Its major clients include university teaching hospitals, children’s hospitals, regional hospital networks, major commercial laboratories and clinics, group-purchasing organizations, and military and government facilities. ARUP is headquartered in Salt Lake City, Utah, the US.

ARUP Laboratories – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ARUP Laboratories, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ARUP Laboratories, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ARUP Laboratories, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ARUP Laboratories, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ARUP Laboratories, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ARUP Laboratories, Medical Equipment, Deal Details 10
Venture Financing 10
PierianDx Raises USD9.2 Million in Series A Financing Round 10
Partnerships 11
Zacharon Pharma Enters Into Licensing Agreement With Arup Labs For Sensi-Pro Assay 11
IDbyDNA Enters into Agreement with ARUP Laboratories 12
Applied Spectral Imaging Enters into Agreement with ARUP Labs 13
Arup Labs Enters into Agreement with University Hospital Case Medical Center to Distribute Novel DEEPGEN HIV Test 14
Predictive Biosciences Enters Into Co-Marketing Agreement With Arup Labs For CertNDx Bladder Cancer Assays 15
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 16
AB Sciex Enters Into Co-Development Agreement With ARUP Labs 17
ARUP Laboratories – Key Competitors 18
ARUP Laboratories – Key Employees 19
ARUP Laboratories – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Nov 30, 2016: ARUP Laboratories appoints new CMO and director of laboratories 21
Jul 07, 2016: ARUP Laboratories Announces New CEO 22
Product News 23
May 26, 2016: Ultra-fast Meta-genomics Pathogen Detection Software for Diagnosing Infectious Diseases 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
ARUP Laboratories, Medical Equipment, Key Facts 2
ARUP Laboratories, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ARUP Laboratories, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ARUP Laboratories, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ARUP Laboratories, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ARUP Laboratories, Deals By Market, 2011 to YTD 2017 8
ARUP Laboratories, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PierianDx Raises USD9.2 Million in Series A Financing Round 10
Zacharon Pharma Enters Into Licensing Agreement With Arup Labs For Sensi-Pro Assay 11
IDbyDNA Enters into Agreement with ARUP Laboratories 12
Applied Spectral Imaging Enters into Agreement with ARUP Labs 13
Arup Labs Enters into Agreement with University Hospital Case Medical Center to Distribute Novel DEEPGEN HIV Test 14
Predictive Biosciences Enters Into Co-Marketing Agreement With Arup Labs For CertNDx Bladder Cancer Assays 15
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 16
AB Sciex Enters Into Co-Development Agreement With ARUP Labs 17
ARUP Laboratories, Key Competitors 18
ARUP Laboratories, Key Employees 19

★海外企業調査レポート[ARUP Laboratories-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TAS S.p.A. (TAS):企業の財務・戦略的SWOT分析
    TAS S.p.A. (TAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Triskalia:戦略・SWOT・企業財務分析
    Triskalia - Strategy, SWOT and Corporate Finance Report Summary Triskalia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Absa Bank Ltd:企業の戦略・SWOT・財務分析
    Absa Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Absa Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ChemImage Corp:企業の製品パイプライン分析
    Summary ChemImage Corp (ChemImage) is a molecular chemical imaging company that provides hyperspectral imaging technologies. The company develops molecular chemical imaging devices and data fusion tools for anatomic structure imaging, cancer detection and cardiovascular health assessment. It offers …
  • Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Rodos BioTarget GmbH (RBT) is a biopharmaceutical company that develops drug delivery platforms. The company provides products such as targosphere, targobiotics and targovir. Its targosphere finds application in treating various infectious diseases such as virus caused HCV and hepatitis c an …
  • Sanovas Inc:医療機器:M&Aディール及び事業提携情報
    Summary SanovasInc (Sanovas) is a developer of diagnostic solutions that develops access, imaging, measurement, therapeutic technologies and solutions for physician. The company provides imaging technologies, interventional lung, interventional ENT, and interventional uro and gyn products, among oth …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務分析
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Credit Agricole CIB S.A.:企業の戦略的SWOT分析
    Credit Agricole CIB S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Talktalk Telecom Group PLC (TALK):企業の財務・戦略的SWOT分析
    Talktalk Telecom Group PLC (TALK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nichirei Corp (2871):企業の財務・戦略的SWOT分析
    Nichirei Corp (2871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gerdau S.A.:戦略・SWOT・企業財務分析
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Novartis AG:企業のM&A・事業提携・投資動向
    Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • PORR AG (POS):企業の財務・戦略的SWOT分析
    PORR AG (POS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • KemPharm Inc (KMPH):企業の財務・戦略的SWOT分析
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, methylphenidate drug for ADHD; KP201/IR, KP511/ER, KP606/IR and KP746 drugs for the …
  • CommScope Holding Company Inc (COMM):企業の財務・戦略的SWOT分析
    CommScope Holding Company Inc (COMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CGN Power Co Ltd (1816):企業の財務・戦略的SWOT分析
    CGN Power Co Ltd (1816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nationwide Building Society:企業の戦略・SWOT・財務分析
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Lloyds Banking Group Plc:企業のM&A・事業提携・投資動向
    Lloyds Banking Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lloyds Banking Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆